tirzepatide tirzepatide Microdose Compound Tirzepatide

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that offers powerful glycemic control and weight reduction through once-weekly subcutaneous injection

Constipation is also common with retatrutide

In ischemiareperfusion model, albiglutide promotes energetic shift from fatty acid to glucose oxidation, reducing myocardial infarct size and improving contractile function ( Dual GLP-1R/GIP receptor agonists co-stimulate both GLP-1R and GIP receptor, and enhance insulinotropic and antihyperglycemic effects compared with selective GLP-1R agonists (Finan et al., 2013)

While Tirzepatide is generally well-tolerated, some individuals may experience mild side effects such as nausea or gastrointestinal discomfort

She is a miracle worker